Cargando…
A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children
PURPOSE: In June 2013, following recommendations from the World Health Organization (WHO) and Food and Drug Administration (FDA), the European Medicines Agency agreed updates to the codeine product information regarding use for pain in children younger than 12 years and children undergoing tonsillec...
Autores principales: | Hedenmalm, Karin, Blake, Kevin, Donegan, Katherine, Macia, Miguel‐Angel, Gil, Miguel, Williams, Julie, Montero, Dolores, Candore, Gianmario, Morales, Daniel, Kurz, Xavier, Arlett, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771637/ https://www.ncbi.nlm.nih.gov/pubmed/31219227 http://dx.doi.org/10.1002/pds.4836 |
Ejemplares similares
-
Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in Children
por: Candore, Gianmario, et al.
Publicado: (2020) -
Prescribing Patterns of Codeine and Alternative Medicines in Children in Europe
por: Plueschke, Kelly, et al.
Publicado: (2022) -
Ability of Primary Care Health Databases to Assess Medicinal Products Discussed by the European Union Pharmacovigilance Risk Assessment Committee
por: Flynn, Robert, et al.
Publicado: (2020) -
EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection
por: Postigo, Rodrigo, et al.
Publicado: (2018) -
Prior cholecystectomy predisposes to acute pancreatitis in codeine-prescribed patients
por: Turkmen, Serdar, et al.
Publicado: (2015)